Approval · Notice of Compliance 22850 · 2019
RAPAMUNE: Notice of Compliance 22850
Issued November 1, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22850
- Date
- November 1, 2019
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- To revise part iii of the rapamune product monograph, package insert and outer labels with regard to ethanol content in oral solution and instructions for use of oral solution
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAPAMUNE | Not yet assigned | — |